Sanjeev Sethi1, Benjamin Madden2, Hanna Debiec3, Johann Morelle4,5, M Cristine Charlesworth2, LouAnn Gross6, Vivian Negron6, David Buob3,7, Sidharth Chaudhry8, Michel Jadoul4,5, Fernando C Fervenza9, Pierre Ronco3,10. 1. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota sethi.sanjeev@mayo.edu. 2. Medical Genome Facility, Proteomics Core, Mayo Clinic, Rochester, Minnesota. 3. Unité Mixte de Recherche S 1155, Sorbonne Université, Université Pierre et Marie Curie Paris 06 and Institut National de la Santé et de la Recherche Médicale, Paris, France. 4. Division of Nephrology, Cliniques universitaires Saint-Luc, Brussels, Belgium. 5. Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. 6. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. 7. Department of Pathology, Tenon Hospital, Paris, France. 8. Ross University School of Medicine, Miramar, Florida. 9. Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota. 10. Division of Nephrology, Centre Hospitalier du Mans, Le Mans, France.
Abstract
BACKGROUND: Membranous nephropathy (MN) results from deposition of antigen-antibody complexes along the glomerular basement membrane (GBM). PLA2R, THSD7A, NELL1, and SEMA3B account for 80%-90% of target antigens in MN. METHODS: We performed laser microdissection and mass spectrometry (MS/MS) in kidney biopsies from 135 individuals with PLA2R-negative MN, and used immunohistochemistry/immunofluorescence and confocal microscopy to confirm the MS/MS finding, detect additional cases, and localize the novel protein. We also performed MS/MS and immunohistochemistry on 116 controls and used immunofluorescence microscopy to screen biopsy samples from two validation cohorts. Western blot and elution studies were performed to detect antibodies in serum and biopsy tissue. RESULTS: MS/MS studies detected a unique protein, protocadherin 7 (PCDH7), in glomeruli of ten (5.7%) PLA2R-negative MN cases, which also were negative for PLA2R, THSD7A, EXT1/EXT2, NELL1, and SEMA3B. Spectral counts ranged from six to 24 (average 13.2 [SD 6.6]). MS/MS did not detect PCDH7 in controls (which included 28 PLA2R-positive cases). In all ten PCDH7-positive cases, immunohistochemistry showed bright granular staining along the GBM, which was absent in the remaining cases of PLA2R-negative MN and control cases. Four of 69 (5.8%) cases in the validation cohorts (all of which were negative for PLA2R, THSD7A, EXT1, NELL1, and SEMA3B) were PCDH7-positive MN. Kidney biopsy showed minimal complement deposition in 12 of the 14 PCDH7-associated cases. Confocal microscopy showed colocalization of PCDH7 and IgG along the GBM. Western blot analysis using sera from six patients showed antibodies to nonreduced PCDH7. Elution of IgG from frozen tissue of PCDH7-associated MN showed reactivity against PCDH7. CONCLUSIONS: MN associated with the protocadherin PCDH7 appears to be a distinct, previously unidentified type of MN.
BACKGROUND: Membranous nephropathy (MN) results from deposition of antigen-antibody complexes along the glomerular basement membrane (GBM). PLA2R, THSD7A, NELL1, and SEMA3B account for 80%-90% of target antigens in MN. METHODS: We performed laser microdissection and mass spectrometry (MS/MS) in kidney biopsies from 135 individuals with PLA2R-negative MN, and used immunohistochemistry/immunofluorescence and confocal microscopy to confirm the MS/MS finding, detect additional cases, and localize the novel protein. We also performed MS/MS and immunohistochemistry on 116 controls and used immunofluorescence microscopy to screen biopsy samples from two validation cohorts. Western blot and elution studies were performed to detect antibodies in serum and biopsy tissue. RESULTS: MS/MS studies detected a unique protein, protocadherin 7 (PCDH7), in glomeruli of ten (5.7%) PLA2R-negative MN cases, which also were negative for PLA2R, THSD7A, EXT1/EXT2, NELL1, and SEMA3B. Spectral counts ranged from six to 24 (average 13.2 [SD 6.6]). MS/MS did not detect PCDH7 in controls (which included 28 PLA2R-positive cases). In all ten PCDH7-positive cases, immunohistochemistry showed bright granular staining along the GBM, which was absent in the remaining cases of PLA2R-negative MN and control cases. Four of 69 (5.8%) cases in the validation cohorts (all of which were negative for PLA2R, THSD7A, EXT1, NELL1, and SEMA3B) were PCDH7-positive MN. Kidney biopsy showed minimal complement deposition in 12 of the 14 PCDH7-associated cases. Confocal microscopy showed colocalization of PCDH7 and IgG along the GBM. Western blot analysis using sera from six patients showed antibodies to nonreduced PCDH7. Elution of IgG from frozen tissue of PCDH7-associated MN showed reactivity against PCDH7. CONCLUSIONS: MN associated with the protocadherin PCDH7 appears to be a distinct, previously unidentified type of MN.
Authors: Sanjeev Sethi; Jason D Theis; Nelson Leung; Angela Dispenzieri; Samih H Nasr; Mary E Fidler; Lynn D Cornell; Jeffrey D Gamez; Julie A Vrana; Ahmet Dogan Journal: Clin J Am Soc Nephrol Date: 2010-09-28 Impact factor: 8.237
Authors: Shane A Bobart; Shahrzad Tehranian; Sanjeev Sethi; Mariam P Alexander; Samih H Nasr; Casal Moura Marta; Julie A Vrana; Samar Said; Callen D Giesen; John C Lieske; Fernando C Fervenza; An S De Vriese Journal: Mayo Clin Proc Date: 2021-03 Impact factor: 7.616
Authors: An S De Vriese; Richard J Glassock; Karl A Nath; Sanjeev Sethi; Fernando C Fervenza Journal: J Am Soc Nephrol Date: 2016-10-24 Impact factor: 10.121
Authors: Marco Prunotto; Maria Luisa Carnevali; Giovanni Candiano; Corrado Murtas; Maurizio Bruschi; Emilia Corradini; Antonella Trivelli; Alberto Magnasco; Andrea Petretto; Laura Santucci; Silvia Mattei; Rita Gatti; Francesco Scolari; Peter Kador; Landino Allegri; Gian Marco Ghiggeri Journal: J Am Soc Nephrol Date: 2010-02-11 Impact factor: 10.121
Authors: Sanjeev Sethi; Hanna Debiec; Benjamin Madden; Marina Vivarelli; M Cristine Charlesworth; Aishwarya Ravindran; LouAnn Gross; Tim Ulinski; David Buob; Cheryl L Tran; Francesco Emma; Francesca Diomedi-Camassei; Fernando C Fervenza; Pierre Ronco Journal: Kidney Int Date: 2020-06-11 Impact factor: 10.612
Authors: Aishwarya Ravindran; Marta Casal Moura; Fernando C Fervenza; Samih H Nasr; Mariam P Alexander; Mary E Fidler; Loren P Herrera Hernandez; Pingchuan Zhang; Joseph P Grande; Lynn D Cornell; Lou Ann Gross; Vivian Negron; Grace E Jenson; Benjamin J Madden; M Cristine Charlesworth; Sanjeev Sethi Journal: J Am Soc Nephrol Date: 2021-01-21 Impact factor: 10.121
Authors: Marc Fila; Hanna Debiec; Hélène Perrochia; Nabila Djouadi; Marie-Christine Verpont; David Buob; Pierre Ronco Journal: J Am Soc Nephrol Date: 2022-01-11 Impact factor: 10.121
Authors: Rebecca I Spain; Nicole K Andeen; Pamela C Gibson; Mary H Samuels; Cynthia D Morris; Andrew J Solomon; Richard Solomon; Carin Waslo; Rupali S Avasare Journal: Kidney Int Date: 2021-10-16 Impact factor: 10.612
Authors: Tiffany N Caza; Samar I Hassen; Daniel J Kenan; Aaron Storey; John M Arthur; Christian Herzog; Rick D Edmondson; T David Bourne; Laurence H Beck; Christopher P Larsen Journal: Kidney360 Date: 2021-06-11
Authors: Sanjeev Sethi; Benjamin Madden; Marta Casal Moura; Samih H Nasr; Nattawat Klomjit; LouAnn Gross; Vivian Negron; M Cristine Charlesworth; Mariam P Alexander; Nelson Leung; Ulrich Specks; Fernando C Fervenza; Mark Haas Journal: J Am Soc Nephrol Date: 2022-03-23 Impact factor: 14.978